Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica

Abstract

The objective of this study was to examine the factors influencing adherence to medications in a group of patients with systemic lupus erythematosus (SLE) in Jamaica. A qualitative study was designed using a screening questionnaire and semi-structured interviews. The study was conducted in the rheumatology clinic at the University Hospital of the West Indies, Kingston, Jamaica. 75 patients with SLE including 20 interviewees, who had SLE for at least 1 year participated in the study. The main outcome measures were: (i) level of self-reported adherence in a sample of the clinic attendees and (ii) interviewees explanations of the reasons for taking or not taking drugs as prescribed by their physician. 56% of the 75 study participants reported taking their medications more than 85% of the time. High cost and poor availability of medications were the main reasons for poor adherence, but some patients chose not to take their medications because of side effects, perceived mild severity of their disease and/or a preference to take drugs only when symptomatic. Patients used herbal medicines to counteract side effects of Western medicines, to ‘purge the blood’ and to manage lupus symptoms when they had no medications. Religious beliefs were used as a coping strategy. Traditional use of herbal medicines is common particularly in patients from rural Jamaica, and may explain the observed use of herbal medicines in those who have emigrated to developed countries. Socio-economic constraints and poor drug availability are particularly important influences on poor adherence in Jamaican patients with SLE. Religious beliefs and use of herbal remedies do not seem to affect adherence adversely but are used when drugs cannot be obtained.

Keywords

adherence medications systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

1 Hopkinson ND Doherty M Powell RJ . The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989–1990. Br J Rheumatol 1993; 32: 110 – 115 .

2 Korbet SM Schwartz MM Evans J Lewis EJ . Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244 – 254 .

3 Bastian HM Roseman JM McGwin G . Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152 – 160 .

4 Adler M Chambers S Edwards C Neild G Isenberg D . An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) 2006; 45: 1144 – 1147 .

5 Petri M Perez-Gutthann S Longenecker JC Hochberg M . Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991; 91: 345 – 353 .

6 Mosley-Williams A Lumley MA Gillis M Leisen J Guice D . Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 2002; 47: 630 – 638 .

9 Wilson WA Hughes GR . Rheumatic disease in Jamaica. Ann Rheum Dis 1979; 38: 320 – 325 .

10.

10 Nossent JC . Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis 1992; 51: 1197 – 1201 .

11.

11 Johnson AE Gordon C Palmer RG Bacon PA . The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 551 – 558 .

12.

12 Williams W Bhagwandass A Sargeant LA Shah D . Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients. Lupus 2003; 12: 640 – 645 .

13.

13 Smikle MF James OB Barton EN DeCeulaer K . More severe disease course and higher mortality in Jamaican patients with lupus erythematosus (SLE). Trop Geogr Med 1995; 47: 231 .

14.

14 Harris EN Williams E Shah DJ DeCeulaer K . Mortality of Jamaican patients with systemic lupus erythematosus. Br J Rheumatol 1989; 28: 113 – 117 .

15.

15 Garcia Popa-Lisseanu MG Greisinger A Richardson M . Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol 2005; 32: 913 – 919 .

16.

16 Holley JL DeVore CC . Why all prescribed medications are not taken: results from a survey of chronic dialysis patients. Adv Perit Dial 2006; 22: 162 – 166 .

17.

17 Wamala S Merlo J Bostrom G Hogstedt C Agren G . Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care 2007; 19: 134 – 140 .

18.

18 Mishra P Hansen EH Sabroe S Kafle KK . Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis 2005; 9: 1134 – 1139 .

19.

19 Lawton J Ahmad N Hallowell N Hanna L Douglas M . Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ 2005; 330: 1247 .

20.

21.

21 Piette JD Heisler M . Problems due to medication costs among VA and non-VA patients with chronic illnesses. Am J Manag Care 2004; 10: 861 – 868 .

22.

22 Piette JD Heisler M Wagner TH . Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health 2004; 94: 1782 – 1787 .

23.

23 Fletcher P McDonald A McCartney T Carpenter R . Surgery in Jamaica. Arch Surg 2003; 138: 1150 – 1153 .

24.

25.

26.

27.

27 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 .

28.

29.

29 Bryman A Burgess R . Analysing qualitative data. London : Routledge ; 1994.

30.

30 Pope C Ziebland S Mays N . Qualitative research in health care. Analysing qualitative data. BMJ 2000; 320: 114 – 116 .

31.

31 Pullar T Peaker S Martin MF Bird HA Feely MP . The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol 1988; 27: 381 – 384 .

32.

32 Mattson RH Cramer JA Collins JF . Aspects of compliance: taking drugs and keeping clinic appointments. Epilepsy Res Suppl 1988; 1: 111 – 117 .

33.

34.

34 Bobb-Liverpool B Duff EM Bailey EY . Compliance and blood pressure control in women with hypertension. West Indian Med J 2002; 51: 236 – 240 .

35.

35 Duff EM O'Connor A Farlane-Anderson N Wint YB Bailey EY Wright-Pascoe RA . Self-care, compliance and glycaemic control in Jamaican adults with diabetes mellitus. West Indian Med J 2006; 55: 232 – 236 .

36.

36 Gardner JM Grant D Hutchinson S Wilks R . The use of herbal teas and remedies in Jamaica. West Indian Med J 2000; 49: 331 – 335 .

37.

37 Connell P McKevitt C Wolfe C . Strategies to manage hypertension: a qualitative study with black Caribbean patients. Br J Gen Pract 2005; 55: 357 – 361 .

38.

38 Leong KP Pong LY Chan SP . Why lupus patients use alternative medicine. Lupus 2003; 12: 659 – 664 .

39.

39 Mishra P Hansen EH Sabroe S Kafle KK . Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis 2005; 9: 1134 – 1139 .

40.

40 Ohene Buabeng K Matowe L Plange-Rhule J . Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Sci 2004; 7: 350 – 352 .

41.

42.